Correction to: Bone Marrow Transplantation https://doi.org/10.1038/s41409-022-01575-z, published online 16 February 2022

The authors realized that the content of the figure legends for Figure 3 and Supplementary Figure 1 was inaccurate. Since readers may attempt to use this novel scoring system for respiratory virus infection outcomes in different cohorts in the future, they would like to propose this revision. Of note, figures themselves do not need to be modified as they are still accurate.

The legends should read as follows:

Figure 3. Cumulative incidence of progression to LRTI within 90 days among patients presenting with URTI by virus type, stratified by immunodeficiency scoring index as well as number of risk factors.

Gray’s test was used to compare cumulative incidence probabilities between categories. Risk factors were age >=40 years, lowest albumin values within 2 weeks before URTI <=3 g/dL, a history of multiple HCT, systemic steroid use within 2 weeks before URTI, early timing post-HCT (<=30 days), monocytopenia within 2 weeks before URTI (<=100 x106 cells/L) and highest glucose values within 2 weeks before URTI >200 mg/dl.

LRTI  lower respiratory tract infection, HRV  human rhinoviruses, PIV  parainfluenza viruses 1-4, COV  seasonal coronavirus, RSV = respiratory syncytial virus, ISI  immunodeficiency scoring index.

Supplementary Figure 1. Cumulative incidence of progression to LRTI within 90 days among patients presenting with URTI by virus type, stratified by immunodeficiency scoring index as well as number of risk factors (Complementary to Figure 3).

Gray’s test was used to compare cumulative incidence probabilities between categories. Risk factors were age >=40 years, lowest albumin values within 2 weeks before URTI <=3 g/dL, a history of multiple HCT, systemic steroid use within 2 weeks before URTI, early timing post-HCT (<=30 days), monocytopenia within 2 weeks before URTI (<=100 x106 cells/L) and highest glucose values within 2 weeks before URTI >200 mg/dl.

LRTI  lower respiratory tract infection, FLU  influenza, MPV  human metapneumovirus, ADV  adenovirus, ISI  immunodeficiency scoring index.

The original article has been corrected.